drugset / Trial / NCT03129568

Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy

NCT03129568 ↗

NaSingle-groupOpen-labelTreatment

Summary

A phase 1 prospective study to determine the procedural feasibility and safety and preliminary efficacy of intracoronary infusion of cardiosphere-derived cells (CDCs) in patients with dilated cardiomyopathy.

Timeline

Start
2017-04-14
Primary completion
2018-09-17
Completion
2020-12-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CDC infusion Cell therapy 300000 cells/kg Other